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Background: Dengue fever is the most prevalent mosquito-borne viral disease worldwide. Dengue transmission is
critically dependent on climatic factors and there is much concern as to whether climate change would spread the
disease to areas currently unaffected. The occurrence of autochthonous infections in Croatia and France in 2010
has raised concerns about a potential re-emergence of dengue in Europe. The objective of this study is to estimate
dengue risk in Europe under climate change scenarios.
Methods: We used a Generalized Additive Model (GAM) to estimate dengue fever risk as a function of climatic variables
(maximum temperature, minimum temperature, precipitation, humidity) and socioeconomic factors (population density,
urbanisation, GDP per capita and population size), under contemporary conditions (1985–2007) in Mexico. We then used
our model estimates to project dengue incidence under baseline conditions (1961–1990) and three climate change
scenarios: short-term 2011–2040, medium-term 2041–2070 and long-term 2071–2100 across Europe. The model was
used to calculate average number of yearly dengue cases at a spatial resolution of 10 × 10 km grid covering all land
surface of the currently 27 EU member states. To our knowledge, this is the first attempt to model dengue fever risk
in Europe in terms of disease occurrence rather than mosquito presence.
Results: The results were presented using Geographical Information System (GIS) and allowed identification of areas
at high risk. Dengue fever hot spots were clustered around the coastal areas of the Mediterranean and Adriatic seas
and the Po Valley in northern Italy.
Conclusions: This risk assessment study is likely to be a valuable tool assisting effective and targeted adaptation
responses to reduce the likely increased burden of dengue fever in a warmer world.
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Several vector-borne diseases are spread in Europe and
the effect of climate change on disease distribution has
been extensively discussed [1-5]. Most authors consider
that climate change is likely to have greatest impact on
dengue fever, West Nile fever, chikungunya fever, mal-
aria, leishmaniasis, tick-borne encephalitis, Lyme borre-
liosis, Crimean-Congo haemorrhagic fever, spotted fever
rickettsioses, Yellow fever and Rift Valley fever. One dis-
ease that has received much interest in recent years is den-
gue fever. Dengue is a mosquito-borne disease caused by* Correspondence: m.bouzid@uea.ac.uk
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unless otherwise stated.an RNA virus of the genus Flavivirus. Uncomplicated den-
gue can present with fever, headache and muscle and joint
pains. A proportion of infections can develop into severe
forms namely dengue haemorrhagic fever and dengue
shock syndrome, which are associated with higher mor-
tality rates. Dengue fever is endemic in over 100 coun-
tries in Africa, the Americas, the Eastern Mediterranean,
South-east Asia and the Western Pacific, with the last
two regions being the most seriously affected [6]. It is es-
timated that over 50 million new dengue fever infections
and approximately 12,000 deaths, mainly among children,
occur worldwide every year [7].
There has been a significant global increase in dengue
incidence and it is currently considered the most importantLtd. This is an Open Access article distributed under the terms of the Creative
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of dengue has been attributed to various factors including
population growth, urbanization, global travel, and envir-
onmental conditions. In Europe, dengue fever is rare but
cases are imported every year by tourists returning from
endemic areas. Recently, autochthonous dengue cases have
been reported in Croatia and France, highlighting the suit-
ability of these regions for dengue transmission [8,9]. These
cases have raised concerns about the potential for the
emergence of dengue fever in Europe especially with pre-
dicted climate change.
One of the reasons for these concerns is that dengue vec-
tors are already present within Europe. Aedes (Stegomyia)
aegypti (Linneaus) is the major urban vector of dengue
worldwide [10]. A. aegypti is closely associated with
humans and human habitations. Female mosquitoes lay
their eggs on or near water surface in natural or artificial
containers [10,11]. Aedes albopictus is the secondary vector
of dengue fever and is adapted to the peridomestic envir-
onment [12]. According to the “European Network for
arthropod vector surveillance for human public health”
(VBORNET) (http://www.vbornet.eu/, last accessed June
2014), A. albopictus is present in many European countries:
Spain, France, Switzerland, Italy, Slovenia, Croatia, Bosnia
and Herzegovina, Serbia, Montenegro, Albania, Greece,
Monaco, San Marino, Bulgaria, the Netherlands and Russia.
By contrast, A. aegypti has only been reported from
Madeira, the Netherlands, Georgia and southern Russia.
There is much debate about how future climate change
will affect dengue risk, especially in countries where the
disease is not currently endemic [10,13,14]. Recent studies
have modelled the future dengue distribution under pre-
dicted climate change either on a global scale [15-19] or in
endemic countries [20,21]. These models have suggested a
latitudinal and altitudinal expansion of the geographical
range of dengue.
In Europe, there have been too few dengue cases to
conduct a rigorous analysis. Consequently, estimation of
dengue risk has so far relied on past, current and pro-
jected future distribution of A. albopictus [22]. Although
presence of the vector is necessary for dengue to become
endemic, vector presence is not sufficient in itself to deter-
mine disease occurrence [23]. The objective of this study is
to model dengue risk based on clinical data. We have used
one of the largest and more spatially diverse dengue dataset
yet assembled to compute significant relationships between
dengue and weather parameters [24]. Subsequently, the
model outputs were used to project dengue risk across
Europe under climate change scenarios.
Methods
Mexican data
The dengue dataset was primarily developed for a study of
the effects of weather on dengue incidence across Mexico[24]. Dengue data comprised state-specific monthly reports
of laboratory confirmed dengue cases, retrieved from
the Mexican Health Secretariat (http://www.epidemiologia.
salud.gob.mx/anuario/html/anuarios.html, last accessed
June 2014) for the period January 1985 to December
2007. Monthly average minimum and maximum tem-
peratures and monthly precipitation for each state were
provided by the Mexican National Meteorological Service.
Monthly mean humidity was retrieved from the National
Centers for Environmental Prediction and National Center
for Atmospheric Research (NCEP/NCAR) “Reanalysis 1”
(http://www.esrl.noaa.gov/psd/data/gridded/data.ncep.
reanalysis.pressure.html, last accessed June 2014). Yearly
Gross domestic product (GDP) per capita (PPP in con-
stant 2005 international dollars) was obtained from the
World Bank at the national level (http://data.worldbank.
org/country/mexico, last accessed June 2014). State-
specific GDP estimates were computed as previously
described [24]. The proportion of people living in urban
areas was retrieved from the Mexican Chamber of Deputies
(http://www.cefp.gob.mx/intr/bancosdeinformacion/estatales/
indicadores_socioeconomicos/is003.xls, last accessed June
2014). Population density was calculated by normalising
population to state area size. Table 1 presents the sum-
mary statistics for these variables.
Model calibration
Generalized Additive Models (GAMs) are semi-parametric
extensions of the generalized linear model (GLM), where
the linear predictor ΣβjXj is replaced by a sum (hence the
name additive) of smooth functions of covariates Σsj(Xj)
[25]. Like in GLMs, GAMs allow the exploration of nonlin-
ear data structures in the context of exponential family
distributions (e.g. Poisson and Binomial), and use link
functions to establish relationships between the mean of
the outcome variable and the predictors [26,27]. Unlike
GLMs, GAMs automatically identify and estimate the opti-
mal degree of nonlinearity of the model directly from the
data [28]. In our study, the expected number of dengue
cases E(yti) ≡ μit for State i at time t was assumed to follow
an overdispersed Poisson distribution described by:
g μtið Þ ¼ β0 þ log ξ tið Þ þ
XJ
j¼1
sj Xjti
 þ
XK
k¼1
βk Zktið Þ
where g(.) is a log link function of the expectation
μit ≡ E(yti) with yti denoting the time series of dengue
counts. The logarithm of the population (ξ) at time t and
state i is included as an exposure variable to standardise
the dengue data by population. Weather has a delayed ef-
fect on dengue incidence. Therefore, we specified our
j-th meteorological variables Xjti within biologically and
physically plausible time lags based on literature reports
in Mexico [29-31]. Weather variables comprised average
Table 1 Summary of statistical characteristics of the
climatic and socioeconomic variables used for this
study in Mexico and Europe
Mean s.d Min Max
Mexican data
Population density 260.22 989.96 3.6 5923.8
Urban population 71.72 15.59 35.72 100
GDP 10.55 5.11 4.31 33.16
Tmin 13.29 5.58 −2.87 24.88
Tmax 28.5 4.39 13.32 39.95
Precipitation 72.73 88.49 0 802.45
Humidity 70.79 17.66 13.34 97.41
European data
Baseline conditions
Population density 105.06 360 0 14820.6
Urban population 16.82 31.3 0 100
GDP 23.57 8.78 4.62 129
Tmin 4.52 6.92 −16.57 24.01
Tmax 12.3 10.05 −11.84 44.09
Precipitation 70.98 39 0 620.19
Humidity 81.08 14.01 25.69 97.75
2011-2040
Tmin 5.01 7.24 −15.79 24.75
Tmax 12.82 10.5 −10.55 44.45
Precipitation 69.6 39.53 0 650.34
Humidity 80.5 14.76 25.82 97.99
2041-2070
Tmin 6.60 6.91 −14.44 26.66
Tmax 14.52 10.4 −8.88 46.46
Precipitation 69.98 39.64 0 628.87
Humidity 79.76 15.89 24.35 98.25
2071-2100
Tmin 7.92 6.88 −12.21 28.4
Tmax 15.88 10.54 −7.65 48.45
Precipitation 70.28 42.21 0 718.44
Humidity 79.26 16.51 23.65 98.22
s.d: standard deviation, Min: minimum value, Max: maximum value. Tmin:
minimum temperature, Tmax: maximum temperature. Units of measures:
Population density (number of people/km2), Urban population (% population
living in urban areas), GDP (thousand International dollars), Temperature
(degrees Celsius), Precipitation (milimetres), Humidity (milibars).
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peratures, monthly precipitation (Precip) and average
monthly relative humidity (Humid). All weather parame-
ters were lagged 1 and 2 months (Tmin1:2, Tmax1:2,
Precip1:2, Humid1:2). The term sj(.) corresponds to uni-
variate smooth functions defined by penalized cubic re-
gression splines. We adjusted our model for the effects ofsocioeconomic variables Zkit represented by GDP per
capita, the proportion of the population living in urban
settlements and population density. Socioeconomic vari-
ables entered the model linearly. Analyses were con-
ducted in R version 2.15.0 [32].
Many epidemiological datasets are likely to be domi-
nated by long-term and seasonal trends. Therefore,
adjusting the regression models for these patterns is
necessary to separate them from the effects of weather
parameters on the health variable [33]. Our model does
not account for seasonal trends as seasonality for Europe
is unlikely to be similar to Mexico given the wider range
of temperatures between summer and winter. Although
mosquito presence is a key factor in the epidemiology
and occurrence of the disease, to our knowledge there
are no state-specific long-term time series of mosquito
presence across Mexico. Consequently, data on mosquito
presence could not be incorporated into our model. The
GAM-estimated relationships between dengue, weather
and socioeconomic development in Mexico were then
used to project dengue fever risk across Europe.
European data and dengue fever risk modelling
European climate data were retrieved from the regional
climate model COSMO-CLM (CCLM), forced with out-
put from the coupled atmosphere–ocean global climate
model (GCM) ECHAM5/MPIOM [34]. These regional
simulations represent aerosol and GHG forcing according
to the A1B scenario of the Special Report on Emissions
Scenarios (SRES) of the IPCC [35]. A1B corresponds to a
projected increase in global surface temperature of 2.8°C
in 2090–2099 (relative to 1980–1999) and a likely range of
up to 4.4°C [36]. It assumes rapid economic growth, rapid
introduction of efficient technologies, convergence among
regions and a balance across energy sources. The regional
climate data correspond to the period 1961–2100, with a
domain covering the entire European continent at a reso-
lution of about 18 × 18 km. Data were re-scaled to a grid
cell size of 10 × 10 km for the purpose of this study. The
same four monthly climatic variables (Tmin, Tmax,
Precip, Humid) lagged 1 and 2 months, as used for model
calibration with the Mexican data, were calculated over
four time periods, (a) baseline 1961–1990, (b) short-term
scenario 2011–2040, (c) medium-term scenario 2041–
2070, and (d) long-term scenario 2071–2100.
GDP per capita data were retrieved from EUROSTAT
(in Euros) and converted into constant 2005 inter-
national dollars to be concordant with the Mexican data
used for model calibration. Country level data from the
World Development Indicators dataset (http://databank.
worldbank.org/data/Databases.aspx, last accessed June
2014) were disaggregated to NUTS-3 level (Nomenclature
of territorial units for statistics) by using the NUTS-3 level
shares for each country as calculated from EUROSTAT.
Table 2 Model estimates of the effects of weather and
socioeconomic variables on dengue
Smooth terms edf F
s(Tmin averaged over previous 2 months) 3.95 68.05†††
s(Tmax averaged over previous 2 months) 3.28 32.91†††
s(Humidity averaged over previous 2 months) 3.94 127.80†††
s(Precipitation total over previous 2 months) 2.85 16.90†††
Linear terms Estimate SE
Intercept −15.52 0.48
Population density −0.0028 0.0004†††
Urbanisation 0.026 0.002†††
GDP −0.0041 0.007
Log Population 2.54 0.070†††
Explained deviance 44.2%
GCV score 124.8
†††Significant at the 0.0001 level.
edf = effective degrees of freedom of the smooth function terms (edf >1 indicate
nonlinear relationships); F value is an approximate F-test, SE = asymptotic standard
error. GCV =Generalized Cross Validation.
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vert the NUTS-3 data into the 10 × 10 km grid (see
Additional file 1). Areal weighting is commonly used to
transform administrative boundary data to raster format,
whereby each grid cell is assigned a value according to
the percentage of its area covered by the overlying ad-
ministrative region [37].
The proportion of population living in urban areas and
total population data were retrieved from the GEOSTAT
2006 population grid dataset of the European Forum for
Geostatistics (EFGS) (http://www.efgs.info/, last accessed
June 2014) at a spatial resolution of 1 × 1 km. Urban
clusters were defined by two criteria first each grid cell
of 1 × 1 km must have a minimum population density
of 300 people per km2 and second clusters of adjoining
grid cells must accommodate at least 5000 people, in line
with the definitions used by the European Commission
[38]. The total number of urban population for each
10 × 10 km grid cell was extracted and divided by total
population to obtain proportion of population in urban
area (see Additional file 1). Due to the lack of projections
both in terms of SRES scenario and spatial detail, the so-
cioeconomic variables were held constant at their mean
value for baseline conditions in order to isolate the effects
of climate.
Mapping of dengue fever risk
The model was used to project monthly dengue cases,
which were aggregated to calculate the average number
of cases per year for each time period. These were used
to generate dengue risk maps using ArcGIS 10.1 (http://
www.esri.com/software/arcgis, last accessed June 2014).
In total, four maps were produced corresponding to the
time periods of study. Identical class sizes were applied
across all four time periods in order to ensure that value
changes could be observed over time. The map series
employ a bipolar hue progression [39] ranging from green
(no/low risk areas) to bright red (areas with the highest
dengue risk). Moreover, a second map series was gener-
ated, that normalises dengue cases by total population to
derive dengue incidence. We used colours ranging from
blue for no/low risk to cherry brown for high risk areas. In
addition, standard error for each grid cell was calculated.
Standard error values were subjected to the same aggrega-
tion and averaging procedure as for dengue number of
cases and dengue incidence and were used to produce
maps of uncertainty.
Results
The dengue-weather relationships estimated by our
Poisson GAM based on the Mexican data are presented
in Table 2. The model explained 44% of the deviance
within the Mexican dataset. Figure 1 shows the estimated
effects of weather variables on number of dengue cases.All climate parameters were statistically significant in a
highly non-linear way. The greatest effect was associated
with monthly average of minimum temperature followed
by monthly relative humidity (both variables lagged one
and two months). For socioeconomic variables, popula-
tion density, degree of urbanization and log population
were all significantly associated with dengue incidence
(Table 2).
The GAM estimated relationships were used to project
dengue fever risk in Europe under climate change condi-
tions expressed as dengue cases (cases/year/10×10 km
grid). For the baseline period (1960–1990), number of
dengue cases are between 0 and 0.6 for most European
areas, corresponding to an incidence of less than 2 per
100 000 inhabitants (Figures 2 and 3). Over time, an in-
crease in dengue risk is projected, with highest incidence
rates found for the long-term scenario 2070–2100. In-
deed, for the baseline period hardly any grid cell had in-
cidence rate exceeding 10 per 100 000 inhabitants, while
a substantial amount of grid cells are within this cat-
egory when considering the long-term-scenario, mostly
localised in southern Europe. For each estimated dengue
incidence, standard error was calculated and values pre-
sented as maps of uncertainty (Figure 4). The general
trend was that standard errors tend to correlate with in-
cidence rates, as would be expected from a Poisson
model. The maps also highlight that the standard errors
are not consistent across the continent.
It can be seen from Figures 2 and 3 that the risk is not
equally distributed across Europe. Generally, southern
Europe appears at higher risk, with most of the coastal
areas being particularly affected. In contrast, northern
Figure 1 GAM-estimated relationships between average monthly dengue cases and average monthly Tmin (A), Tmax (B), Humidity (C),
and precipitation (D), all lagged 1 and 2 months. The x axis represents increasing variations in the meteorological covariates. The y axis
indicates the contribution of the smoother to the fitted values. The y axis is labelled s(cov, edf), where cov indicates the name of the covariate,
and edf represents the estimated degrees of freedom of the smooth function used to represent its relationship with number of dengue cases.
The red lines indicate the maximum likelihood estimates, and the grey shaded areas represent the 95% confidence intervals. The rug at the
bottom of the figures indicate observed values of the covariates.
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show virtually no risk in the baseline period. Over time,
the risk in southern Europe and in particular along the
Mediterranean coast is projected to increase consider-
ably, with highest incidence revealed along the Italian
coast, the Po Valley region, the Spanish Mediterranean
coast and southern Spain in general (Figures 2 and 3). In
other parts of Europe a change from virtually no risk for
the baseline period to incidence rate of up to 10 cases
per 100 000 inhabitants are projected, such as in large
parts of France, south-western Germany, Hungary, and
the Balkan region. By contrast, in northern Europe, for
most of the British Isles and the Baltic states, the risk is
projected to remain virtually zero even for the long-term
scenario 2070–2100.
Discussion
We have presented the first ever projections of future
dengue fever risk in Europe under climate change based
on empirical modelling of laboratory confirmed dengue
incidence as a function of climate and socioeconomic
variables. Our study has shown that the risk of dengue
fever is likely to increase in Europe under climate
change, but that almost all of the excess risk will fall on the
coastal areas of the Mediterranean and Adriatic seas and
the North Eastern part of Italy, particularly the Po Valley.
Although we have only modelled dengue fever, our findingsmay have implications for other mosquito-borne diseases
such as Chikungunya, which share the same vector species
and may have similar transmission patterns to dengue
fever.
Previous work in the area has primarily focused on the
expected future distribution of the Aedes vector [40-44].
Whilst such studies have proven helpful to determine
the potential presence of the vector in a given area, the
presence of the vector does not necessary translate into
disease occurrence. Because our model is based on dis-
ease occurrence, the GAM-estimated relationships are
likely to be more useful for estimating dengue risk
across Europe than models based only on the mere
presence of the mosquito. Nevertheless, our results are
generally in agreement with the conclusions of projec-
tions based on vector distribution. One such example of
concordance is Italy, which was identified as a potential
dengue hot spot using both approaches (i.e. vector pres-
ence and dengue risk). The most noticeable discrepancies
for dengue fever risk, however, were associated with
Spain and France. In our study, southern and eastern
Spain is associated with increased dengue risk, however,
A. albopictus maps show that this area is likely to be un-
suitable by mid/end century [40-43], probably because of
hotter and drier weather conditions. On the contrary,
France is considered here at medium risk (excluding
Mediterranean areas), while it is considered an area of
Figure 2 Average expected number of dengue cases in Europe modelled using GAM model for baseline conditions and climate
change scenarios for early, medium and late century. Number of cases was calculated for each 10 × 10 km grid.
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nations for these discrepancies include different climate
change scenarios and dissimilar climatic variables incorpo-
rated in modelling approaches. A recent study by Rogers
and colleagues established a dengue risk map for Europebased on a global risk map taking into account vector pres-
ence, disease occurrence and various environmental factors
[45]. They showed that while most Europe is at low risk,
most major cities combining warmer temperatures and
higher population density are highly suitable for dengue
Figure 3 Dengue fever incidence rate expressed as number of cases per 100 000 inhabitants per year for baseline conditions and
climate change scenarios for early, medium and late century.
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eral other factors can influence disease occurrence and
transmission. In our study, most cities are not at an in-
creased risk until mid to end of the century. Understand-
ably, it is difficult to compare two risk maps generatedusing different methodologies and data sets. Nevertheless,
European dengue hot spots identified in this and other
studies should be made aware of the projected risk.
Herein, we identified a large European geographical
area permissive for dengue fever transmission. Whether
Figure 4 Maps of uncertainty showing standard errors for projected average number of dengue cases for baseline conditions and
climate change scenarios for early, medium and late century.
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on various climatic and non-climatic factors, in addition
to disease risk in neighbouring areas, which makes estima-
tion of actual incidence problematic. Nevertheless, dengue
is unlikely to become endemic in areas of moderate risk,especially if nearby areas have low risk. Consequently we
would hypothesise that, should dengue fever become
endemic in Europe, it is likely to be primarily in the
Mediterranean and Adriatic coastal plains and the Po
Valley area of Italy. This does not mean that localised
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if they did, they would be less likely to be self-sustaining.
For the purpose of this study, we have used Mexican
dengue fever surveillance data to project dengue inci-
dence in Europe. This could be considered a limitation
because of applicability to European settings and trans-
ferability issues. It would clearly have been preferable to
use European dengue data but at present there have
been too few cases in Europe for any meaningful ana-
lysis. In the absence of worthwhile European data, the
Mexican dengue surveillance dataset is without doubt
the best alternate source of empirical data. The Mexican
dataset comprises the largest such set yet assembled with
monthly data and sub-national resolution. Furthermore,
Mexico is a large country comprising multiple climate
zones and thus providing the opportunity of modelling cli-
mate impacts on dengue over a wide range of climatic
conditions. Mexico is a middle income country, whose
socioeconomic status could be comparable to some
European countries http://data.worldbank.org/data-catalog/
world-development-indicators (last accessed June 2014).
Nevertheless, there are several mismatches. One particular
issue is seasonal climatic variation, as seasons in Mexico
may not match those in Europe. For example, Mexico
is highly affected by the El Niño–Southern Oscillation
[46], which does not have such an impact in Europe.
Similarly, winter climatic conditions can be very differ-
ent between Mexico and Europe, therefore influencing
overwintering and survival of Aedes populations. In order
to test for this variability, we fitted the model with and
without the seasonal term and found that the shape
of the estimated relationships graph was similar with
a slight difference in order of magnitude. Additional
file 2 shows the range of the two weather variables
most significantly associated with dengue risk (Tmin and
humidity). There is a major area of overlap between the
two sufficient to give validity to the use of the Mexico
data. The major European areas that do not overlap with
Mexico are unlikely to be in areas at risk from dengue.
Another important point to consider is the different
socioeconomic conditions and cultural habits between
Mexico and Europe. Whilst we were not able to model
many of these differences due to the absence of adequate
data, some of the variables may have little impact on
overall dengue risk. For instance, GDP was not found to
be significantly associated with dengue fever risk. How-
ever, this could be due to data constrains because GDP
were available as yearly data that arose from linear inter-
polations based on 5 years interval. Taking into account
these constraints, we have been careful not to be too spe-
cific about how many extra cases of dengue we are likely
to see in Europe, rather on identifying high risk areas.
Clearly even in highly conducive areas, dengue fever will
not become endemic if it is not introduced at some pointand so the development and spread of dengue endemicity
is likely to be a stochastic process, nevertheless it is
relying on vector presence, virus introduction and host
susceptibility.
An important issue is that the model is produced for a
country where dengue is endemic. If dengue was intro-
duced into Europe, then it could spread rapidly in the
early years of its establishment and become endemic.
This is because almost all Europeans would be immuno-
logically naïve and therefore actual cases could outstrip
our projections. A further source of uncertainty would
be the adaptation of the European health authorities to
the emergence of dengue, including health practitioners’
awareness and effective diagnostic and treatment mea-
sures. However, even well-staffed health services with
adequate infrastructure could struggle to manage dengue
fever [23]. Further response measures that could lower
transmission rate, while awaiting the development of an
effective vaccine, should include integrated vector man-
agement. However, the effectiveness of vector control
strategies is not always supported by adequate evidence
based evaluations [47]. In addition, unless vector control
is performed in a sustainable manner, it is most likely to
be inefficient.
Another limitation of the study is related to the
mosquito vector. Although, A. albopictus is present in
Mexico, dengue is mainly transmitted by A. aegypti. This
primary dengue vector is responsible for major dengue
epidemics and the severe life- threatening form of the
disease [12]. In Europe, A. aegypti is only present in
Madeira, where it caused sporadic cases and a sustained
dengue outbreak [48]. The main Aedes species in Europe
is A. albopictus. This species is associated with sporadic
dengue cases due to its limited competence related to its
feeding behaviour and its relative recent adaptation to
flaviviruses (including dengue fever virus) [49]. Conse-
quently, our results are likely to over-estimate dengue
risk in Europe. Additionally, some dengue virus sero-
types were shown to cause more severe symptoms and
spread more easily [50], therefore the impact of dengue
introduction in Europe and subsequent transmission is
influenced by virus-vector interaction and the associ-
ated risk and severity could either increase or decrease
accordingly. Nevertheless, living standards in Europe are
likely to limit dengue spread as has been reported in Texas
[51], consequently, the actual dengue incidence could be
much lower than projected using our model.
One finding that may cause some concern is that
under baseline conditions some areas are identified as
being at increased risk of dengue fever, when dengue in
Europe is effectively non-existent. This is legitimate
because the model is projecting areas where, given the pro-
vided meteorological and socioeconomic conditions, den-
gue fever may occur, independently of other confounding
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control measures. Undoubtedly, some European areas are
permissive for dengue fever transmission as supported by
endogenous cases in France and Croatia in 2010 [8,9]. The
French cases were recorded in Nice, which was indeed
highlighted as high risk area in our model. Croatian cases
were on the Peljesac peninsula and the island of Korcula
(outside the EU27 and therefore not modelled here). Fur-
thermore, in 2007, there was an outbreak of Chikungunya
(another viral disease spread by A. albopictus mosquitoes)
that affected north eastern Italy on the Adriatric coast
[52,53]. Although Chikungunya virus shows adaptive mu-
tation for A. albopictus [49], not observed for dengue virus,
this area is clearly permissive for the mosquito vector and
is associated with the highest projected dengue fever risk
in our model. These sporadic cases and outbreaks confirm
the general spatial pattern of dengue risk as estimated by
our model.
An issue valid for both Mexico and Europe is that
Mexican dengue fever data is based on laboratory con-
firmed reported cases of infection. While on one hand,
and in particular for Europe, our approach of modelling
dengue risk based on reported cases is considered novel
and unique, on the other hand such reports are known
to substantially underestimate the actual number of
cases because a significant proportion of infections are
not diagnosed and reported. A limitation of dengue sur-
veillance in Mexico is its reliance on a passive surveillance
system based on unspecific symptoms, coupled with low
awareness of health practitioners and limited access to reli-
able diagnostic tests. Estimation of the sensitivity of dengue
surveillance systems varies inter and intra countries but it
has been reported that for every recorded case, there may
be somewhere between 10–27 cases that go unreported
[54]. This could mean that the number of dengue fever
cases could be substantially higher than estimated here. It
is not known what the sensitivity of dengue surveillance
systems in Europe would be, however, asymptomatic and
mild cases could go undiagnosed.
In order to assess the impact of climate change on
dengue risk in Europe, we used predictions based on the
A1B scenario because it is considered more realistic in
light of the current global emissions. This is particularly
relevant when compared to other more extreme scenar-
ios (such as the low emission SRES B1, or the newer
RCP2.6 scenarios) that assume drastic CO2 reductions
globally in the coming decades, which is unlikely to hap-
pen. Running the current model using additional climate
change scenarios would add value to the predictions and
allow comparative analysis and could be done as a sub-
sequent study. In order to assess the effect of climate
change on dengue risk, all non-climatic variables were
assumed to remain at their baseline levels, while this
could be considered a limitation, some socioeconomicvariables were not significantly associated with dengue
risk. In addition, population and urbanisation projec-
tions for Europe show that minor changes are expected
(with some local variation), especially when compared to
other parts of the world (where significant increase in
population size and urbanisation are expected until 2100)
(http://esa.un.org/wpp/ and http://esa.un.org/unpd/wup/
last accessed August 2014).
A recent systematic review of quantitative models
assessing the impact of climate change on dengue trans-
mission by Naish and colleagues [55] found that despite
using different methodologies, most models consider that
temperature is the most important climatic factor driving
dengue transmission but that precipitation and humidity
are also important, which is in accordance with our
model. Despite some methodological issues, most models
report increased climatic suitability and expansion of geo-
graphical range under various climate change scenarios
and in different regions of the world [55]. Improved cli-
mate change scenarios and better understanding of vector-
borne diseases biology and transmission are likely to con-
tribute to more accurate disease risk models in the future.
Conclusions
This study allowed modelling of dengue fever risk in
Europe based on actual clinical data. The model cali-
brated under Mexican conditions resulted in reliable and
geographically meaningful patterns of projected dengue
fever risk in Europe. The risk maps indicate that climate
change is likely to contribute to increased dengue risk
(and possibly other mosquito-borne diseases) in many
parts of Europe, especially towards the end of the century.
The areas of greatest increased risk are projected to be
clustered around the Mediterranean and Adriatic coasts
and in northern Italy. The exact incidence is dependent
on several other factors, some of which we were unable to
model at this stage (such as vaccine development). Never-
theless public health agencies in high risk areas need to
plan, implement and evaluate active entomological report-
ing and sentinel clinical surveillance and should aim to
improve awareness of the increased risk amongst health
practitioners and the general public.
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